Crews Bank & Trust’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
JFG
Crews Bank & Trust's ARKG Position: Q2 2026 in Review
Crews Bank & Trust sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 700 shares — an estimated $18.5K sold.
Crews Bank & Trust first reported a position in ARKG in Q4 2024 and held it in 6 quarters. The position peaked at $20.3K in Q4 2025. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.
- Crews Bank & Trust reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
- Crews Bank & Trust sold 700 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $18.5K.
- Crews Bank & Trust first reported a position in ARK Genomic Revolution ETF in Q4 2024 and held it in 6 quarters.
- Crews Bank & Trust's ARK Genomic Revolution ETF position peaked at $20.3K in Q4 2025.
- 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.
Based on Crews Bank & Trust's 13F filing for Q2 2026, filed 16 Jul 2026.